Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second Edition.

Autor: Vogt GS, Avendaño-Ortega M, Schneider SC, Goodman WK, Storch EA
Jazyk: angličtina
Zdroj: Journal of psychiatric practice [J Psychiatr Pract] 2022 Jul 01; Vol. 28 (4), pp. 294-309. Date of Electronic Publication: 2022 Jul 01.
DOI: 10.1097/PRA.0000000000000640
Abstrakt: The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) is a widely used measure for assessing the presence and severity of obsessive-compulsive disorder symptoms. The Yale-Brown Obsessive-Compulsive Scale-Second Edition (Y-BOCS-II) was developed, in part, to more comprehensively evaluate symptom severity, especially in extremely ill patients, and improve consistency in detecting and incorporating avoidance behaviors. We present 3 case studies that demonstrate the enhanced ability of the Y-BOCS-II to: (1) detect fluctuations in symptom severity among extremely ill patients, (2) systematically incorporate avoidance variables for more accurate ratings, and (3) maintain strong convergence with the Y-BOCS in assessing patients presenting with mild to moderate symptoms. In addition, we outline how to obtain both Y-BOCS and Y-BOCS-II scores within 1 administration by adding Y-BOCS item 4 to the Y-BOCS-II assessment, then "back-coding" the Y-BOCS-II ratings to Y-BOCS ratings and using Y-BOCS item 4 in place of Y-BOCS-II item 2. The use of this method allows for more robust data collection while providing comparability across the literature.
Competing Interests: W.K.G. received an honorarium from Biohaven Pharmaceuticals. He receives research grant support from NIH, the McNair Foundation, and Biohaven Pharmaceuticals. He receives donated medical devices from Medtronic. E.A.S. receives book royalties from Elsevier, Jessica Kingsley, American Psychological Association, Springer, Lawrence Erlbaum, and Wiley. He is a consultant for Biohaven and Brainsway. He holds stock in NView. He receives grant support from NIH, Ream Foundation, Texas Higher Education Coordinating Board, Greater Houston Community Foundation. The remaining authors declare no conflicts of interest.
(Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze: MEDLINE